vs
Side-by-side financial comparison of IMAX CORP (IMAX) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $76.2M, roughly 1.6× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 0.5%, a 6.9% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 25.5%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $9.7M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 22.7%).
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
IMAX vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $125.2M | $76.2M |
| Net Profit | $637.0K | $5.6M |
| Gross Margin | 57.6% | 57.9% |
| Operating Margin | 19.3% | 11.0% |
| Net Margin | 0.5% | 7.4% |
| Revenue YoY | 35.1% | 25.5% |
| Net Profit YoY | -88.0% | 30.7% |
| EPS (diluted) | $0.02 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $125.2M | $76.2M | ||
| Q3 25 | $106.7M | $71.9M | ||
| Q2 25 | $91.7M | $63.1M | ||
| Q1 25 | $86.7M | $59.1M | ||
| Q4 24 | $92.7M | $60.7M | ||
| Q3 24 | $91.5M | $58.0M | ||
| Q2 24 | $89.0M | $55.0M | ||
| Q1 24 | $79.1M | $50.6M |
| Q4 25 | $637.0K | $5.6M | ||
| Q3 25 | $20.7M | $3.5M | ||
| Q2 25 | $11.3M | $3.2M | ||
| Q1 25 | $2.3M | $2.6M | ||
| Q4 24 | $5.3M | $4.3M | ||
| Q3 24 | $13.9M | $3.9M | ||
| Q2 24 | $3.6M | $1.5M | ||
| Q1 24 | $3.3M | $1.6M |
| Q4 25 | 57.6% | 57.9% | ||
| Q3 25 | 63.1% | 57.5% | ||
| Q2 25 | 58.5% | 58.3% | ||
| Q1 25 | 61.4% | 56.3% | ||
| Q4 24 | 52.2% | 59.5% | ||
| Q3 24 | 55.8% | 59.3% | ||
| Q2 24 | 49.4% | 59.8% | ||
| Q1 24 | 59.3% | 58.9% |
| Q4 25 | 19.3% | 11.0% | ||
| Q3 25 | 27.2% | 7.8% | ||
| Q2 25 | 15.6% | 8.1% | ||
| Q1 25 | 19.3% | 6.5% | ||
| Q4 24 | 10.3% | 10.6% | ||
| Q3 24 | 21.2% | 9.7% | ||
| Q2 24 | 3.2% | 6.6% | ||
| Q1 24 | 15.3% | 4.4% |
| Q4 25 | 0.5% | 7.4% | ||
| Q3 25 | 19.4% | 4.9% | ||
| Q2 25 | 12.3% | 5.0% | ||
| Q1 25 | 2.7% | 4.4% | ||
| Q4 24 | 5.7% | 7.1% | ||
| Q3 24 | 15.2% | 6.7% | ||
| Q2 24 | 4.0% | 2.7% | ||
| Q1 24 | 4.1% | 3.2% |
| Q4 25 | $0.02 | $0.14 | ||
| Q3 25 | $0.37 | $0.09 | ||
| Q2 25 | $0.20 | $0.08 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $0.09 | $0.10 | ||
| Q3 24 | $0.26 | $0.10 | ||
| Q2 24 | $0.07 | $0.04 | ||
| Q1 24 | $0.06 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $151.2M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $337.9M | $141.5M |
| Total Assets | $894.0M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $151.2M | $13.5M | ||
| Q3 25 | $143.1M | $11.1M | ||
| Q2 25 | $109.3M | $20.0M | ||
| Q1 25 | $97.1M | $10.2M | ||
| Q4 24 | $100.6M | $17.5M | ||
| Q3 24 | $104.5M | $11.3M | ||
| Q2 24 | $91.6M | $8.8M | ||
| Q1 24 | $81.0M | $7.3M |
| Q4 25 | $337.9M | $141.5M | ||
| Q3 25 | $349.5M | $133.6M | ||
| Q2 25 | $320.4M | $139.7M | ||
| Q1 25 | $299.5M | $134.8M | ||
| Q4 24 | $299.5M | $131.4M | ||
| Q3 24 | $289.4M | $125.0M | ||
| Q2 24 | $267.2M | $119.4M | ||
| Q1 24 | $258.8M | $116.3M |
| Q4 25 | $894.0M | $199.2M | ||
| Q3 25 | $889.6M | $202.4M | ||
| Q2 25 | $868.6M | $184.6M | ||
| Q1 25 | $848.3M | $178.1M | ||
| Q4 24 | $830.4M | $177.1M | ||
| Q3 24 | $847.6M | $169.5M | ||
| Q2 24 | $827.4M | $163.9M | ||
| Q1 24 | $824.1M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.4M | $18.4M |
| Free Cash FlowOCF − Capex | $28.0M | $9.7M |
| FCF MarginFCF / Revenue | 22.3% | 12.7% |
| Capex IntensityCapex / Revenue | 1.1% | 11.5% |
| Cash ConversionOCF / Net Profit | 46.11× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $118.9M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.4M | $18.4M | ||
| Q3 25 | $67.5M | $18.4M | ||
| Q2 25 | $23.2M | $12.3M | ||
| Q1 25 | $7.0M | $2.9M | ||
| Q4 24 | $11.5M | $15.0M | ||
| Q3 24 | $35.3M | $12.7M | ||
| Q2 24 | $35.0M | $10.2M | ||
| Q1 24 | $-11.0M | $1.2M |
| Q4 25 | $28.0M | $9.7M | ||
| Q3 25 | $64.8M | $10.7M | ||
| Q2 25 | $20.9M | $4.1M | ||
| Q1 25 | $5.3M | $-12.6M | ||
| Q4 24 | $6.9M | $3.2M | ||
| Q3 24 | $34.2M | $1.7M | ||
| Q2 24 | $33.5M | $1.2M | ||
| Q1 24 | $-12.1M | $-4.8M |
| Q4 25 | 22.3% | 12.7% | ||
| Q3 25 | 60.7% | 14.9% | ||
| Q2 25 | 22.8% | 6.5% | ||
| Q1 25 | 6.1% | -21.4% | ||
| Q4 24 | 7.4% | 5.2% | ||
| Q3 24 | 37.3% | 3.0% | ||
| Q2 24 | 37.6% | 2.3% | ||
| Q1 24 | -15.3% | -9.5% |
| Q4 25 | 1.1% | 11.5% | ||
| Q3 25 | 2.6% | 10.6% | ||
| Q2 25 | 2.6% | 12.9% | ||
| Q1 25 | 1.9% | 26.2% | ||
| Q4 24 | 5.0% | 19.5% | ||
| Q3 24 | 1.2% | 19.0% | ||
| Q2 24 | 1.8% | 16.3% | ||
| Q1 24 | 1.4% | 11.9% |
| Q4 25 | 46.11× | 3.27× | ||
| Q3 25 | 3.27× | 5.23× | ||
| Q2 25 | 2.06× | 3.88× | ||
| Q1 25 | 2.99× | 1.09× | ||
| Q4 24 | 2.16× | 3.47× | ||
| Q3 24 | 2.54× | 3.29× | ||
| Q2 24 | 9.78× | 6.94× | ||
| Q1 24 | -3.35× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
VMD
Segment breakdown not available.
